Centre for Addiction and Mental Health
People
Alexandre Guet-McCreight
Lead investigator
Chao Zheng
Lead investigator
Lead investigator
Shreejoy Tripathy
Lead investigator
Bonnie Lee
Lead investigator
Lead investigator
Lead investigator
Lead investigator
Stuart Matan-Lithwick
Lead investigator
Lead investigator
Senior vice president
Lead investigator
Lead investigator
Lead investigator
Lead investigator
Sanjeev Kumar
Lead investigator
Lead investigator
Lead investigator
Lead investigator
Sources: openalex.org, reporter.nih.gov
Trials
Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use Disorder
Phase 2, Recruiting, 30 people, Feb 12, 2026
Phase 2, Recruiting, 40 people, Oct 8, 2025
Technology-Enabled Collaborative Care for Diabetes and Mental Health
Collaborator, Recruiting, 160 people, Sep 18, 2025
Phase 4, Recruiting, 35 people, Aug 7, 2025
Collaborator, Phase 2, Terminated, 30 people, Feb 24, 2025
Psilocybin for Treatment-Resistant Depression in Autism
Phase 1, Active, not recruiting, 18 people, Dec 12, 2024
Treatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND)
Phase 2, Recruiting, 16 people, Jul 24, 2024
Phase 2, Recruiting, 12 people, Jul 22, 2024
Collaborator, Phase 1, Active, not recruiting, 30 people, Jul 17, 2024
Phase 1, Completed, 10 people, Mar 7, 2024
Collaborator, Phase 3, Completed, 76 people, Dec 1, 2023
Does Psilocybin Change Synaptic Density in Amnestic Mild Cognitive Impairment
Phase 2, Completed, 10 people, Sep 18, 2023
Collaborator, Phase 3, Active, not recruiting, 1,500 people, Jul 13, 2023
Phase 4, Recruiting, 100 people, Feb 27, 2023
Phase 4, Completed, 20 people, Feb 15, 2023
Phase 2, Completed, 41 people, Feb 2, 2023
Phase 2, Completed, 48 people, Jan 20, 2023
Phase 4, Completed, 87 people, Sep 8, 2022
Phase 4, Recruiting, 1,200 people, Aug 25, 2022
Collaborator, Phase 4, Recruiting, 400 people, Aug 23, 2021
Sources: clinicaltrials.gov
Grants and prizes
HORIZON-RIA, Away From Keyboard (AFK) Youth: Advancing Treatment for Gaming Disorder through Youth Centred, Multimodal Interventions, 101286745, €2.7M, 2027–2032, Lead, Nov 16, 2026
Canada Foundation for Innovation | Fondation canadienne pour l'innovation
Sex and sex-specific factors influencing brain health across the lifespan, 95rn-3a63, 2026, Jun 26, 2026
Gouvernement du Canada | Canadian Institutes of Health Research
Fellowship - Priority Announcement: Aging, Linking cellular and synaptic changes in human aging to clinically-relevant brain signal biomarkers of age-related cognitive decline, 194080_1, CA$206K, 2024–2027, Jul 1, 2024
Gouvernement du Canada | Canadian Institutes of Health Research
Project Grant, Develop in vivo PET imaging probes for ROCK2 as a biomarker of early Alzheimer's disease., 191769_1, CA$761K, 2024–2029, Apr 1, 2024
Gouvernement du Canada | Canadian Institutes of Health Research
OG: ISTG:Eval. of Progr., Services/Innovative Models of Care for People Impacted by Dementia-Stream 1ye-Azrieli Found. for aging w/neurodiversity Pool, Evaluating implementation of a dementia screening program for people with intellectual and/or developmental disabilities in community agencies across Canada: Facilitators, barriers and next steps for spread and scale, 195325_1, CA$750K, 2024–2027, Apr 1, 2024
Gouvernement du Canada | Canadian Institutes of Health Research
Project Grant, Identifying genetics and brain imaging-based biomarkers of neuron-type specific vulnerability in late life, 191747_1, CA$792K, 2024–2029, Apr 1, 2024
Gouvernement du Canada | Canadian Institutes of Health Research
Travel Awards - Institute Community Support, Parity differentially influences neuroplasticity and neuroinflammation at middle age depending on APOEe4 genotype, 191431_1, CA$2K, 2024, Jan 1, 2024
Gouvernement du Canada | Canadian Institutes of Health Research
Op. Gr.:Brain Health/Reduction of Risk for Age-related Cognitive Impairment - Knowledge Synthesis/Mobili. Grants - Vascular Cognitive Impairment (VCI), Helping Women with Diabetes Quit Smoking: A Gender-Informed Approach to Brain Health, 191187_1, CA$98.8K, 2023–2024, Nov 1, 2023
Gouvernement du Canada | Canadian Institutes of Health Research
Operating Grant: Factors and Mechanisms that Impact Cognitive Health in Aging - Caregiving and Care Providers and/or Aging with Neurodiversity, Promoting brain health: A national capacity building project for aging adults with intellectual or developmental disabilities, family caregivers and service providers, 191304_1, CA$749K, 2023–2026, Nov 1, 2023
Gouvernement du Canada | Canadian Institutes of Health Research
Project Grant, Outcomes and disease burden in a model of young adult multimorbidity, 190102_1, CA$987K, 2023–2028, Oct 1, 2023
Gouvernement du Canada | Canadian Institutes of Health Research
Project Grant, Outcomes and disease burden in a model of young adult multimorbidity, 185840_1, CA$100K, 2023–2024, Apr 1, 2023
Gouvernement du Canada | Canadian Institutes of Health Research
Planning and Dissemination Grant - Institute Community Support, Building a Plan for Embedding Preventative Cancer Screening into Specialized Mental Health Services in Canada, 183433_1, CA$10K, 2022–2023, Jun 1, 2022
Gouvernement du Canada | Canadian Institutes of Health Research
CIHR Fellowship, Engaging Patients and Families in the Planning, Discovery, and Dissemination of Genomic, 181796_1, CA$152K, 2022–2025, May 1, 2022
Gouvernement du Canada | Canadian Institutes of Health Research
Project Grant, Metformin for Antipsychotic-induced Weight Gain in Adults with Intellectual Disability Study: a Double-Blind Randomized Control Trial, 178072_1, CA$761K, 2021–2026, Oct 1, 2021
National Institute of Mental Health
R01, 1/5 Neurocognitive and neuroimaging biomarkers: predicting progression towards dementia in patients with treatment-resistant late-life depression, R01MH114970, $410K, 2017–2024, Jul 13, 2021
Gouvernement du Canada | Canadian Institutes of Health Research
Project Grant - PA: Epigenetics/epigenomics in human health or disease, Investigating the role of accelerated neuronal aging in a mouse model of Huntington's disease from a circadian epigenomic perspective., 175377_1, CA$100K, 2021–2022, Mar 1, 2021
Gouvernement du Canada | Canadian Institutes of Health Research
Project Grant, Motherhood and brain aging: the effects of hormone therapy, immune and metabolic challenges later in life, 173554_1, CA$884K, 2020–2025, Oct 1, 2020
Gouvernement du Canada | Canadian Institutes of Health Research
Project Grant, Semaglutide in comorbid obesity and schizophrenia-spectrum disorders for metformin non-responders: a double-blind randomized control trial, 168965_1, CA$861K, 2020–2025, Apr 1, 2020
National Institute of Mental Health
R01, Evaluation of molecular mechanisms of treatment response in late-life depression, R01MH118311, $517K, 2019–2023, Mar 17, 2020
National Institute of Mental Health
R01, The SenDep Study: Linking Molecular Senescence Changes to Depression and Cognitive Impairment in Late Life, R01MH115953, $526K, 2019–2023, Dec 19, 2019
Sources: cordis.europa.eu, openalex.org, reporter.nih.gov
Funded papers
Aug 4, 2026
Lifestyle and BrainAGE in adult depression
Jul 27, 2026
Copy number variant scores are associated with cerebrovascular pathology in aging
Jul 3, 2026
May 30, 2026
Management of brain-heart multimorbidity: a clinical practice guideline
Mar 29, 2026
Executive Function Among Older Adults With Bipolar Disorder: A GAGE-BD Analysis
Dec 7, 2025
Jul 24, 2025
May 15, 2025
Examining the Role of Neuroticism Polygenic Risk in Late Life Cognitive Change: A UK Biobank Study
Sep 29, 2024
Sep 12, 2023
Multi-omic integration via similarity network fusion to detect molecular subtypes of ageing
Apr 4, 2023
Discovery Fund, Jan 18, 2023
Older molecular brain age in severe mental illness
Jul 6, 2020
Statins and cognition in late-life bipolar disorder
Jul 19, 2018
May 2, 2017
Feb 16, 2017
Feb 9, 2017
Does high dose vitamin D supplementation enhance cognition?: A randomized trial in healthy adults
Feb 4, 2017
Systematic Review of Cognitive Effects of Electroconvulsive Therapy in Late-Life Depression
Mar 8, 2016
Sources: openalex.org, api.crossref.org
Papers
Journal of hypertension, Nov 18, 2026
Aging measure linked to smaller brain regions in young adults
Translational psychiatry, Nov 4, 2026
The Aging Brain Matrix: Cross-Species Evidence Linking FREM3 to Brain and Cognitive Aging
Research Square, Oct 30, 2026
Psychological Distress as a Pathway Linking Personality Traits to Episodic Memory in Older Adults
Behavioral sciences (Basel, Switzerland), Oct 29, 2026
Losing the Frem3 gene lowers brain volume in aging mice
bioRxiv, Oct 28, 2026
Lifestyle and BrainAGE in adult depression
Translational psychiatry, Oct 23, 2026
Playing music shares genetic links with healthy aging
Research Square, Oct 22, 2026
The International journal on drug policy, Oct 10, 2026
Reframing menopause and menopause hormone therapy as opportunities for healthy aging
Science (New York, N.Y.), Oct 2, 2026
medRxiv : the preprint server for health sciences, Sep 24, 2026
Prenatal stress and its relationship with inflammaging and cognitive performance in young adulthood
Research Square, Sep 16, 2026
Chest, Sep 3, 2026
Brain cell changes linked to cognitive decline in older people
Nature medicine, Aug 26, 2026
PloS one, Aug 18, 2026
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, Aug 14, 2026
Journal of affective disorders, Aug 6, 2026
medRxiv, Aug 4, 2026
Age at menopause, APOE-ε4, and Alzheimer's disease risk
Research square, Aug 1, 2026
Expanded Alcohol Screening and Brief Intervention to Address Premature Mortality
JAMA health forum, Jul 31, 2026
Biological psychiatry. Cognitive neuroscience and neuroimaging, Jul 31, 2026